Based on 258 English grammar books, Language Between Description and Prescription investigates nineteenth-century grammar writing relating to actual language change, especially in the verb phrase. Lieselotte Andewald proposes that not all changes were noticed in the first place, and those that were noticed were not necessarily criticized. The book also demonstrates that though grammars were prescriptivist, their effect was at best minimal.
This book is a detailed examination of social connections to language evaluation with a specific focus on the values associated with both prescriptivism and descriptivism. The chapters, written by authors from many different linguistic and national backgrounds, use a variety of approaches and methods to discuss values in linguistic prescriptivism. In particular, the chapters break down the traditional binary approaches that characterize prescriptive discourse to create a view of the complex phenomena associated with prescriptivism and the values of those who practice it. Most importantly, this volume continues serious academic conversations about prescriptivism and lays the foundation for continued exploration.
Language Between Description and Prescription is an empirical, quantitative and qualitative study of nineteenth-century English grammar writing, and of nineteenth-century language change. Based on 258 grammar books from Britain and North America, the book investigates whether grammar writers of the time noticed the language changing around them, and how they reacted. In particular, Lieselotte Anderwald demonstrates that not all features undergoing change were noticed in the first place, those that were noticed were not necessarily criticized, and some recessive features were not upheld as correct. The features investigated come from the verb phrase and include in particular variable past tense forms, which -although noticed-often went uncommented, and where variation was acknowledged; the decline of the be-perfect, where the older form (the be-perfect) was criticized emphatically, and corrected; the rise of the progressive, which was embraced enthusiastically, and which was even upheld as a symbol of national superiority, at least in Britain; the rise of the progressive passive, which was one of the most violently hated constructions of the time, and the rise of the get-passive, which was only rarely commented on, and even more rarely in negative terms. Throughout the book, nineteenth-century grammarians are given a voice, and the discussions in grammar books of the time are portrayed. The book's quantitative approach makes it possible to examine majority and minority positions in the discourse community of nineteenth-century grammar writers, and the changes in accepted opinion over time. The terms of the debate are also investigated, and linked to the wider cultural climate of the time. Although grammar writing in the nineteenth century was very openly prescriptivist, the studies in this book show that many prescriptive dicta contained interesting grains of descriptive detail, and that eventually prescriptivism had only a small-scale, short-term effect on the actual language used.
This book contextualises case studies across a wide variety of languages and cultures, crystallising key interrelationships between linguistic standardisation and prescriptivism, and between ideas and practices. It focuses on different traditions of standardisation and prescription throughout the world and addresses questions such as how nationalistic idealisations of ‘traditional’ language persist (or shift) amid language change, linguistic variation and multilingualism. The volume explores issues of standardisation and the sociolinguistic phenomenon of prescription as a formative influence on the notional standard language as well as the interconnections between these in a wide range of geographical contexts. It balances the otherwise strong emphasis on English in English language publications on prescriptivism and breaks new ground with its multilingual approach across languages and nations. The book will appeal to scholars working within different linguistic traditions interested in questions relating to all aspects of standardisation and prescriptivism.
To maintain their own health and the health of their families and communities, consumers rely heavily on the health information that is available to them. This information is at the core of the partnerships that patients and their families forge with today's complex modern health systems. This information may be provided in a variety of forms â€" ranging from a discussion between a patient and a health care provider to a health promotion advertisement, a consent form, or one of many other forms of health communication common in our society. Yet millions of Americans cannot understand or act upon this information. To address this problem, the field of health literacy brings together research and practice from diverse fields including education, health services, and social and cultural sciences, and the many organizations whose actions can improve or impede health literacy. Health Literacy: Prescription to End Confusion examines the body of knowledge that applies to the field of health literacy, and recommends actions to promote a health literate society. By examining the extent of limited health literacy and the ways to improve it, we can improve the health of individuals and populations.
Physician-historian Jeremy A. Greene examines the mechanisms by which drugs and chronic disease categories define one another within medical research, clinical practice, and pharmaceutical marketing, and he explores how this interaction has profoundly altered the experience, politics, ethics, and economy of health in late-twentieth-century America.
Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected. Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective. Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks. Additional Columbia / SSRC books on the privatization of risk and its implications for Americans: Bailouts: Public Money, Private ProfitEdited by Robert E. Wright Disaster and the Politics of InterventionEdited by Andrew Lakoff Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein
The first authoritative look at the history of the prescription itself, Prescribed is a groundbreaking book that subtly explores the politics of therapeutic authority and the relations between knowledge and practice in modern medicine.
